Kerecis Overview

  • Founded
  • 2009
  • Status
  • Private
  • Employees
  • 101
  • Latest Deal Type
  • Debt
  • Latest Deal Amount
  • $6M
Latest Deal Amount
  • Investors
  • 7

Kerecis General Information


Developer of fish skin-based therapeutic products intended to speed up the healing of human wounds and repair tissue damage. The company's therapeutic products contain Omega3 fatty acids extracted from fish skin to reconstruct tissue damage such as burn and diabetic wounds as well as for oral wounds, hernia repair and breast reconstruction, enabling medical practitioners to treat patients' wounds, burns and other dermatological conditions effectively.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • Laugavegur 77
  • Reykjavik, 101
  • Iceland
+354 419 0000

Kerecis Timeline

Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Kerecis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Debt - General 27-Aug-2020 $6M 0000 Completed Generating Revenue
10. Later Stage VC 01-Jul-2020 00000 0000 Completed Generating Revenue
9. Later Stage VC (Series C) 13-Jun-2019 000.00 000.00 Completed Generating Revenue
8. Later Stage VC (Series B2) 23-May-2018 00.000 000.00 Completed Generating Revenue
7. Grant 21-Oct-2016 00.00 Completed Generating Revenue
6. Later Stage VC (Series B1) 01-Oct-2015 00.00 00.00 Completed Generating Revenue
5. Secondary Transaction - Private 01-Jan-2014 00.00 Completed Startup
4. Early Stage VC (Series A3) 01-Dec-2013 00.00 00.00 Completed Startup
3. Early Stage VC (Series A2) 26-Apr-2013 $1.7M $2.3M Completed Startup
2. Early Stage VC (Series A1) 24-May-2011 $200K $600K Completed Startup
To view Kerecis’s complete valuation and funding history, request access »

Kerecis Comparisons

HQ Location
Total Raised
Post Valuation
Last Financing Details
Developer of fish skin-based therapeutic products intended to speed up the healing of human wounds and repair tissue dam
Drug Discovery
Reykjavik, Iceland
101 As of 2021
000000000 0000

00000 00

didunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco
0000 000000000
South San Francisco, CA
00 As of 0000
000000000000 00000

000000 0

m ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et d
Marietta, GA
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Kerecis Competitors (10)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Ambys Medicines Venture Capital-Backed South San Francisco, CA 00 00000 000000000000 00000
000000 0000000 Accelerator/Incubator Backed Marietta, GA 000000000000
000 000000000000 Venture Capital-Backed Boston, MA 00 000.00 0000000000 0 000.00
0000000000000 Corporation Canton, MA 000 00000 00000000 00000
00000 Formerly VC-backed Columbia, MD 000 000.00 000000&0 000.00
You’re viewing 5 of 10 competitors. Get the full list »

Kerecis Executive Team (23)

Name Title Board Seat Contact Info
Gudmundur Fertram Sigurjonsson Co-Founder, Chief Executive Officer, President & Chairman
Mike Cadigan Chief Financial Officer
Christopher Harte Chief Operating Officer, Global Markets & Technologies
Klara Sveinsdottir Business Development Director
Marvin McBride Director Customer Operations
You’re viewing 5 of 23 executive team members. Get the full list »

Kerecis Board Members (11)

Name Representing Role Since
Andri Sveinsson Self Board Member 000 0000
Ernest Kenney Kerecis Co-Founder & Board Member 000 0000
Franck Sinabian Self Board Member 000 0000
Gudmundur Fertram Sigurjonsson Kerecis Co-Founder, Chief Executive Officer, President & Chairman 000 0000
Olafur Grimsson Ph.D Self Board Member 000 0000
You’re viewing 5 of 11 board members. Get the full list »

Kerecis Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Kerecis Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
United States Department of Defense Government 000 0000 000000 0
1924 ehf Other Minority 000 0000 000000 0
Capital ehf Other Minority 000 0000 000000 0
Hradfrystihusid - Gunnvor Hf Other Minority 000 0000 000000 0
Klofningur Ehf Other Minority 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »

Kerecis Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000000000 07-Feb-2019 000000000000000000 Biotechnology 000000000 0000000 000000000000
To view Kerecis’s complete acquisitions history, request access »

Kerecis Subsidiaries (1)

Company Name Industry Location Founded
00000000000000 Biotechnology Adliswil, Switzerland 0000
To view Kerecis’s complete subsidiaries history, request access »